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A B S T R A C T
Introduction. Ejaculation is a complex reﬂex mediated by a spinal ejaculation generator located in the lumbosacral
spinal cord and consisting of a population of lumbar spinothalamic (LSt) neurons. LSt neurons and their intraspinal
axonal projections contain several neuropeptides, including gastrin-releasing peptide (GRP).
Aim. To test the hypothesis that GRP is critically involved in mediating ejaculation by acting in autonomic and
motor areas of the lumbosacral spinal cord, utilizing a physiological paradigm to investigate ejaculatory reﬂexes in
isolation of supraspinal inputs.
Methods. Dual immunohistochemistry for GRP and galanin was performed to investigate co-expression of GRP in
LSt cells of control male rats. Next, anesthetized, spinalized male rats received intrathecal infusions of either GRP
antagonist RC-3095 (0, 10, or 20 nmol/10 mL) or GRP (0, 0.2, 0.5 nmol/10 mL). Ejaculatory reﬂexes were induced
by electrical stimulation of the dorsal penile nerve (DPN) which reliably triggers rhythmic increases in seminal
vesicle pressure (SVP) and contractions of the bulbocavernosus muscle (BCM), indicative of the emission and
expulsion phases of ejaculation, respectively.
Main Outcome Measures. GRP in LSt cells was expressed as percentages of co-expression. SVP and electromyo-
graphic recording (EMG) of BCM activity following drug treatment and DPN stimulation were recorded and
analyzed for numbers of SVP increases, BCM events and bursts.
Results. GRP was exclusively expressed in LSt cells and axons. Intrathecal infusion of RC-3095, but not saline,
blocked SVP increases and BCM bursting induced by DPN stimulation. Intrathecal infusions of GRP, but not saline,
triggered SVP increases and BCM bursting in 43–66% of animals and facilitated SVP increases and BCM bursting
induced by subthreshold DPN stimulation in all animals.
Conclusion. These data support a critical role for GRP for control of the emission and expulsion phases of
ejaculation in male rats by acting in LSt target areas in the lumbosacral spinal cord. Kozyrev N, Lehman MN, and
Coolen LM. Activation of gastrin-releasing peptide receptors in the lumbosacral spinal cord is required for
ejaculation in male rats. J Sex Med 2012;9:1303–1318.
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Introduction
Male sexual behavior is a complex and reward-ing behavior that ultimately results in ejacu-
lation [1]. Ejaculation is deﬁned as the expulsion of
seminal ﬂuid from the urethral meatus [2,3] and
comprises two phases: emission and expulsion.
Emission refers to the secretion of seminal ﬂuids
from the accessory sex glands, contraction of the
ductus deferens, and closure of the bladder neck
and external urethral sphincter. Expulsion refers to
the forceful ejection of semen, which is produced
by the rhythmic contractions of the striated
perineal and smooth muscles of the urethra, and
the bulbocavernosus muscle (BCM) in particular
[4–7].
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It is well known that ejaculation is a reﬂex and
that the central components that regulate the
ejaculatory reﬂex are located in the lumbosacral
spinal cord [3,8]. Indeed, ejaculatory reﬂexes
remain intact in animals and men with complete
spinal cord transection [3,8,9]. Thus, ejaculation is
mediated by a spinal control center, referred to as
a spinal ejaculation generator [2,3,10], spinal
pattern generator [11], or spinal pacemaker [12].
This spinal ejaculation generator is suggested to
coordinate sympathetic, parasympathetic, and
motor outﬂow to induce the emission and expul-
sion phases of ejaculation. In addition, the spinal
ejaculation generator is hypothesized to integrate
this autonomic and motor outﬂow with sensory
inputs associated with the summation of sexual
activity, thereby triggering ejaculation.
The spinal ejaculation generator is composed of
a population of interneurons in the central gray of
lumbar levels L3-4 that play a pivotal role in the
control of ejaculation, and are hypothesized to
convert sensory signals into motor or secretory
outputs [13] (Figure 1). This population of inter-
neurons is located in lamina 10 and the medial
portion of lamina 7 of lumbar segments 3 and 4
(L3-4), contain the neuropeptides galanin, chole-
cystokinin, gastrin releasing peptide, and enkepha-
lin [14–18], and have projections to a nucleus in
the thalamus: the parvocellular subparafascicular
thalamic nucleus [14,16,17]. Based on their ana-
tomical location in the spinal cord and thalamic
projections, these particular cells are referred to as
lumbar spinothalamic (LSt) cells [19].
Moreover, LSt cells have additional characteris-
tics that are consistent with their role as a critical
component of the spinal ejaculation generator.
Mating-related sensory inputs induce activation
of LSt cells, thereby triggering ejaculation
[8,12,20,21]. These sensory inputs are relayed via
the sensory branch of the pudendal nerve, or dorsal
penile nerve (DPN) [22,23] (Figure 1). Mating or
stimulation of the DPN, which reliably triggers
ejaculatory reﬂexes in anesthetized and spinalized
male rats, induces expression of markers of neural
activation cFos [17] and phosphorylated extracellu-
lar signal-regulated kinases 1 and 2 (pERK) [22]
in LSt cells. Moreover, inhibition of mitogen-
activated protein (MAP) extracellular signal-
regulated kinase (MEK) completely abolished
ejaculation induced by DPN stimulation [22].
Therefore, DPN ﬁbers transmit sensory inputs to
LSt cells and, in turn, trigger ejaculation via activa-
tion of the MAP kinase pathway.
LSt cells are ideally positioned to coordinate the
outﬂow necessary for ejaculation (Figure 1). LSt
cells have axonal projections to target regions of the
spinal cord implicated in ejaculatory control
[24–26]. Speciﬁcally, LSt cells project to pregangli-
onic sympathetic neurons in the intermediolateral
cell column (IML) and central autonomic nucleus
(CAN) of the thoracolumbar spinal cord and to the
preganglionic parasympathetic neurons in the sacral
parasympathetic nucleus (SPN) of the lumbosacral
spinal cord [19,26] and motor neurons in the spinal
nucleus of the bulbocavernosus (SNB) [18,25]. LSt
cells and their axonal projections contain several
neuropeptides, including galanin, cholecystokinin,
enkephalin, and gastrin-releasing peptide (GRP)
[14–18]. Thus, we hypothesize that these neuropep-
tides act in the LSt target areas to mediate ejacula-
tory reﬂexes. In support of this hypothesis, GRP, a
member of the family of bombesin-like peptides
[27,28], has been implicated in male erectile and
ejaculatory function in spinally-intactmales utilizing
the ex copula reﬂex paradigm [18].However, in order
to study the role of GRP in ejaculatory reﬂexes, it is
necessary to eliminate supraspinal inﬂuences on the
spinal ejaculation generator.
Therefore, the purpose of the present study was
to test the role of GRP in the control of ejaculation
using a physiologically relevant model of ejacula-
Figure 1 Schematic diagram of the spinal ejaculation gen-
erator. Lumbar spinothalamic (LSt) cells receive sensory
inputs related to the summation of sexual activity via the
dorsal nerve of the penis (DPN), triggering activation of the
LSt cells. LSt cells send axonal projections to preganglionic
sympathetic neurons in the central autonomic nucleus
(CAN) and intermediolateral cell column (IML), to pregan-
glionic parasympathetic neurons in the sacral parasympa-
thetic nucleus (SPN), and to pudendal motorneurons in the
sacral nucleus of the bulbocavernosus (SNB). It is hypoth-
esized that the neuropeptides expressed in the axon termi-
mals of the LSt cells trigger ejaculatory reflexes by acting in
the LSt target areas.
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tion involving electrical stimulation of the DPN in
anesthetized, spinalized male rats. Stimulation of
the DPN reliably triggers ejaculation in all
mammals, including rats [8], monkeys [29], and
humans [30]. Moreover, in anesthetized and spi-
nalized male rats, DPN stimulation elicits rhyth-
mic contractions of the BCM similar to those in
observed in a mating animal during ejaculation
[20,23], and reﬂexive penile erections are evident
[8,31]. The aim of the present study was twofold.
First, it was conﬁrmed that GRP is expressed in
LSt cells and their axon terminals in autonomic
and motor areas in the lumbosacral spinal cord.
Next, it was tested whether GRP receptor activa-
tion is required to trigger the emission and expul-
sion phases of ejaculation and whether GRP is
sufﬁcient to trigger ejaculatory reﬂexes in the
absence of DPN stimulation.
Materials and Methods
Animals
Adult male Sprague Dawley rats (4–5 months)
were obtained from Charles River (Sherbrook,
Quebec, Canada and Wilmington, MA, USA) and
were housed in pairs in standard housing cages on
a 12-hour light/dark cycle with lights off at 10 pm.
Food and water were available ad libitum. All pro-
cedures were approved by the University Commit-
tee on Use and Care of Animals at the University
of Michigan and conform to the guidelines out-
lined by the National Institutes of Health.
Experimental Designs
Intrathecal Infusion of GRP Receptor
Antagonist RC-3095
Male rats were anesthetized with urethane (1.5 g/
kg, i.p.), a laminectomy was performed between
the sixth and the eighth thoracic spinal segments
and the spinal cord was completely transected.
Next, the dorsal penile nerve (DPN) and the
muscle of the bulbocavernosus (BCM) were
exposed and the surrounding connective tissue was
removed. In preparation for electromyographic
(EMG) recordings, silver recording electrodes,
connected to the PowerLab/7SP Data Acquisition
System (AD Instruments, Inc., Colorado Springs,
CO, USA) were inserted bilaterally into the BCM
and a ground electrode was placed into the muscle
of the right thigh. A bipolar stimulating electrode
connected to the SD9 Square Pulse Stimulator
(Grass Technologies, West Warwick, RI, USA)
was positioned directly on top of the DPN. Initial
stimulation of the DPN was performed in order to
verify the completeness of the spinal cord transec-
tion, indicated by a rhythmic bursting pattern of
the BCM (Figure 2). Electrical stimulation of
the DPN comprised square wave pulses of 1 ms
duration, 4 V at 60 Hz for 10 seconds. These
stimulation parameters have previously been dem-
onstrated to trigger rhythmic bursting of the BCM
indicative of the expulsion phase of ejaculation in
100% of control animals [22,23]. Experiments
started 2 hours following transection of the spinal
cord to allow for potential acute effects of spinal
cord transection to subside. A second laminectomy
was performed at spinal level T10 in preparation
for intrathecal administration of neuropeptides. A
small incision was made in the dura mater at the
site of the second laminectomy and a polyethylene
Figure 2 Example of a characteristic BCM EMG activity
induced by DPN stimulation. Dashed lines in the EMG trace
in (A) represent the end of DPN stimulation followed by 90
seconds of EMG recording showing BCM events (activity
above baseline) and clusters of events, i.e., BCM bursts.
Time is presented on horizontal scale (Scale bar in A rep-
resents 20 seconds) and activity amplitude (in mV) on ver-
tical scale. The three bursts indicated by the box (16
seconds of recording) are shown on an enlarged time scale
in (B) to clearly show the clusters of BCM events within
bursts (each burst is indicated by a bracket) and the return
to baseline activity between bursts.
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catheter (Caly-Adams PE-10, Parsippany, NJ,
USA) was inserted into the subarachnoid space at
lumbar levels, to deliver drugs presumably to the
entire lumbosacral spinal cord. First, 10 mL/
minute of saline was infused and BCM EMG
activity was recorded for 25 minutes. Afterwards,
the DPN was stimulated twice with 5-minute
intervals between stimulation, at 30 Hz and 60 Hz
in a counterbalanced manner (testing trial 1;
control trial). BCM activity was recorded for 90
seconds, the time period for a typical BCM burst-
ing activity [22,23]. One hour later, the procedure
was repeated in the same animals, which now
received a 10 mL infusion (over 1 minute) of either
0.9% saline (N = 10) or one of two doses of the
GRP receptor antagonist RC-3095, 20 nmol
(N = 9) and 10 nmol (N = 6) (Sigma-Aldrich
Canada Ltd., Oakville, Ontario, Canada). BCM
activity was recorded for 25 minutes, after which
the DPN was stimulated at 30 Hz and 60 Hz (as
described earlier in a counterbalanced manner),
and the BCM EMG activity was recorded (testing
trial 2; drug trial).
Intrathecal Infusion of GRP20–29 Agonist
A separate group of male rats was anesthetized,
spinalized, and prepared as described previously.
Males received intrathecal 10 mL infusions of
0.9% saline (N = 11) and BCM EMG was
recorded for 10 minutes following infusion. Then,
the DPN was stimulated at 5 HZ, 10 HZ, 30 HZ
and 60 HZ in a randomized and counterbalanced
manner, and BCM EMG was recorded for a period
of 90 seconds following stimulation (testing trial 1;
control trial). One hour after the last DPN stimu-
lation, the procedure was repeated in the same
group of animals, which now received 10 mL
intrathecal infusions of either 0.9% saline (N = 11)
or one of two doses of GRP agonist (GRP20–29
0.2 nmol, N = 7; 0.5 nmol, N = 7 [Phoenix Phar-
maceuticals Inc. USA, Burlingame, CA, USA]) and
BCM EMG was recorded for 10 minutes after
infusion of vehicle or drug. Next, the DPN was
stimulated at 5, 10, 30, and 60 HZ in a counter-
balanced order as described earlier (testing trial 2;
drug trial).
BCM EMG Analysis
BCM EMG recordings were analyzed for the 25
or 10 minutes following the infusion of the
antagonist or agonist, respectively, and for 90
seconds following each DPN stimulation. The
numbers of events and bursts, as well as latencies
to ﬁrst event, were analyzed. The analysis of
numbers of events was performed using LabChart
7 (AD Instruments Inc.), and all events that were
above baseline activity were recorded [22]. In addi-
tion, numbers of bursts were analyzed by two inde-
pendent observers blinded to experimental
treatment groups. Bursts were deﬁned as a group
of 10 or more events, without return to baseline
activity between events. These criteria were based
on a detailed analysis of the BCM bursting activity
in a subgroup of control animals (N = 15). The
average number of events per burst, number of
bursts, and time intervals between successive
bursts during a period of 90 seconds following a 30
or 60 Hz DPN stimulation were calculated. There
was an average of 48.56 (ranging from 10–253) or
62.57 (ranging from 10–315) BCM events per
burst after 30 and 60 Hz DPN stimulation, respec-
tively. Furthermore, there was a mean of 7.4 bursts
(ranging between 3–12 bursts) or 8.07 bursts
(ranging between 4–12 bursts) following 30 or
60 Hz resp. Analysis of time (second) between
bursts revealed that there was an average of 2.54
seconds between successive bursts (ranging from
0.2–7 seconds).
Effects of antagonist treatments on numbers of
events or bursts were compared both within
animals (between the two testing trials [control and
drug trials] and within the same drug treatment
group) and between groups (within each of the two
testing trials, and between drug treatment groups),
separately for the 30 or 60 Hz stimulations, using
two-way repeated anova (factors: Drug treatment
and Testing trial) and Holm-Sidak post hoc tests.
Effects of agonist treatments on numbers of events
or bursts were compared within animals (between
the ﬁve stimulations [following infusion without
stimulation, 5, 10, 30, 60 Hz]) and between treat-
ment groups (within each stimulation setting),
separately for each of the two testing trials, using a
two-way repeated anova (factors: Drug treatment
and Stimulation) and Holm-Sidak post hoc tests. A
95% conﬁdence level was used for all tests.
Immunohistochemistry Experiments
GRP Expression in LSt Cells
In order to verify that LSt cells and their axon
terminals in autonomic and motor areas express
GRP, eight male rats (four spinal intact and four
spinalized 6–8 hours prior) were perfused transcar-
dially with 10 mL 0.9% saline followed by 500 mL
of 4% paraformaldehyde in phosphate buffer (0.1
PB). Spinal cords were removed and postﬁxed for
1 hour in the same ﬁxative and subsequently placed
in cryoprotective solution (20% sucrose in 0.1 PB
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with 0.01% sodium azide) until further processing
for immunohistochemistical detection of GRP and
galanin, a marker for LSt cells [13,17,20,22,23].
DPN Stimulation-induced pERK after RC-3095
To verify that GRP antagonist did not prevent
activation of LSt cells, expression of phosphory-
lation of ERK (pERK) in LSt cells was examined
following stimulation of the DPN [22]. Male rats
(N = 6) were anesthetized and spinalized as
described above. Two hours after spinalization,
the DPN and BCM were exposed and vehicle
(saline, N = 3) or drug (RC-3095; Sigma-Aldrich
Canada Inc.; 20 nmol; N = 3) were infused in a
volume of 10 mL intrathecally as described previ-
ously. Twenty-ﬁve minutes later, the DPN was
stimulated at 30 Hz and BCM EMG activity was
recorded for 90 seconds. Five minutes following
DPN stimulation, animals were perfused tran-
scardially with 5 mL 0.9% saline solution and
500 mL of 4% paraformaldehyde in 0.1 M PB.
Spinal cords were removed and postﬁxed for 1
hour in the same ﬁxative and subsequently placed
in cryoprotective solution (20% sucrose in 0.1 PB
with 0.01% sodium azide) until further processing
for immunohistochemical detection of pERK and
galanin. The stimulation parameters and time of
perfusion were previously shown to be optimal
for visualization of pERK expression in LSt cells
[22] Moreover, it was previously shown that spi-
nalization and exposure of DPN and BCM
without electrical stimulation of the DPN did not
induce pERK expression in LSt cells [22], hence
negative control groups were not included in this
experiment.
Immunohistochemistry
Spinal cords were sectioned using a freezing
microtome (Thermo Fisher Scientiﬁc, Walldorf,
Germany) into 12 parallel series of 35 um coronal
sections in cryoprotectant solution (30% sucrose,
30% ethylene glycol in 0.1 M PB with 0.01%
sodium azide) and stored at -20°C until further
processing. Free ﬂoating sections containing lower
thoracic, lumbar, and sacral spinal levels were
thoroughly rinsed in 0.1 M saline buffered sodium
phosphate (PBS) between incubations and blocked
with 1% H2O2 for 10 minutes prior to incubation.
All antibody incubations were performed in incu-
bation solution containing 0.1% bovine serum
albumin and 0.4% Triton X-100 (BP151-500,
Thermo Fisher Scientiﬁc, Ottawa, Ontario,
Canada) in PBS at room temperature with gentle
agitation.
Galanin/GRP Dual Fluorescence
One series of sections for four animals (two spinal
intact and two spinalized) were dual stained for
galanin and GRP. Sections were incubated over-
night with rabbit anti-galanin (1:60,000; T-4334;
Bachem,Torrance,CA,USA) andwith biotinylated
goat anti-rabbit for one hour (1:500; Vector Labo-
ratories, Burlingame, CA, USA), avidin horserad-
ish peroxidase complex (ABC-elite, 1:1,000 in PBS;
1 hour;VectorLaboratories), biotinylated tyramine
(BT; 1:250 in PBS containing 1 uL/mL of 3%
H2O2 for 10; NEL700/700A; PerkinElmer Life
Sciences, Boston, MA, USA), and Alexa 488-
conjugated streptavidin (1:100 in PBS, 30 minutes
(Jackson ImmunoResearch Laboratories, West
Grove, PA, USA). Next, sections were incubated
with rabbit anti-GRP (1:2,000; Phoenix [H-027-
13]) and Alexa 555-conjugated goat anti-rabbit for
30 minutes in PBS (1:100; Jackson Immuno-
Research Laboratories) and mounted on plus
charged slides, cover-slipped with gelvatol and
stored in the dark at 4°C. One series of sections of
each of four animals (two spinal intact and two
spinalized) was stained using this same procedure,
but were ﬁrst processed forGRP immunoreactivity
(-ir; using rabbit-anti-GRP; 1:40,000) and subse-
quently for galanin (rabbit anti-galanin; 1:3,000).
Galanin/pERK Dual Fluorescence
One series of sections were processed using the
same protocol as described earlier using rabbit
anti-pERK (1:1,000; overnight; Cell Signaling #
26 L) and rabbit anti-galanin (1:3,000).
For all procedures, the omission of primary
antibodies resulted in a complete loss of signal at
speciﬁc wavelengths and all primary antibodies
have been previously characterized [17,22,23].
Data Analysis
Analysis for Galanin/GRP Co-localization
Sections of the lumbosacral spinal cord containing
LSt cells were analyzed for expression of GRP
using a Leica DM5000B (Leica Microsystems,
Wetzlar, Germany). In all eight animals, included
in the analysis, all galanin-ir and CGRP-ir cells
were analyzed for co-expression of GRP-ir or
galanin-ir, respectively. The percentages of
galanin-ir co-expressing GRP and vice versa were
determined for each animal and a group mean was
calculated. In addition, the co-localization of
galanin and GRP was analyzed in LSt axons in the
intermediolateral cell column (IML), central auto-
nomic nucleus (CAN), sacral parasympathetic
nucleus (SPN), and spinal nucleus of the bulbocav-
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ernosus (SNB) using a Zeiss laser-scanning confo-
cal microscope system (Zeiss LSM510; Carl Zeiss
MicroImaging, Inc., Thornwood, NY, USA).
Alexa 555-ﬂuorescence was imaged using a
567 nm emission ﬁlter and a HeNe laser and Alexa
488 was imaged using a 505 nm ﬁlter and Argon
laser. Images were generated by projecting several
1 mm optical sections collected at 1 mm intervals
through areas of interest in the z-axis using a 63x
water-immersion objective.
pERK Expression in LSt Cells
pERK expression in LSt cells was analyzed on a
DM5000B Leica ﬂuorescent microscope (Leica
Microsystems, Wetzlar, Germany). Speciﬁcally, all
lumbar cells expressing galanin-ir were analyzed for
expression of pERK.Data are expressed as themean
percentages of LSt cells that express pERK for each
animal. The group means were calculated and com-
pared between animals that received an infusion of
RC-3095 (20 nmol) and saline-treated controls,
using Student t-tests with 95% conﬁdence levels.
Pressure Recording in Seminal Vesicles
Based on ﬁndings from the above described experi-
ments, an additional experiment was conducted to
analyze pressure in the seminal vesicles (SV), which
is considered an indicator of the emission phase
([32]). Spinal cords were transected, and BCM and
DPNwere exposed as described above. In addition,
the right SV was exposed by coeliotomy. SV pres-
sure (SVP) was measured using a pressure catheter
(AD Instruments Inc., model number: SPR-
671(1.4 F, Single, Straight, 15 cm, Ny) attached to
a catheter interface cable (AD Instruments Inc.,
model number: AEC-IOD) and connected to a
Bridge AMP (AD Instruments Inc.). The pressure
catheter was inserted into the lumen of the SV and
secured prior to recording. SVP and BCM EMG
(as described earlier) were simultaneously recorded
and analyzed using LabChart 7 (AD Instruments
Inc.). There were three groups of animals (N = 3
per group). The ﬁrst group of control animals
received DPN stimulation at 5, 10, 30, and 60 Hz
10minutes after intrathecal saline infusion (control
Trial 1) and identical treatment in trial 2 (control
Trial 2). The second group of animals received
intrathecal saline and DPN stimulation at 30 and
60 Hz 25 minutes later (control Trial 1), and sub-
sequent intrathecal RC-3095 (20 nmol; Trial 2;
drug trial) again followed byDPNstimulation at 30
and 60 Hz 25 minutes after each infusion. The
third group of animals received intrathecal saline
and DPN stimulation at 5,10, 30, and 60 Hz 10
minutes later (Trial 1; control trial) and subsequent
GRP agonist (GRP20–29; Trial 2; drug trial) followed
by DPN stimulation at 5, 10, 30, and 60 Hz 10
minutes after each infusion.
Analysis: BCM EMG was analyzed as described
and numbers of bursts were compared within
animals and between trials 1 and 2 using t-tests or
the Mann-Whitney–Wilcoxon test. SVP was ana-
lyzed using LabChart7 (AD Instruments Inc.).
SVP increased simultaneously with BCM EMG
bursts and the numbers of times that increased
SVP occurred were counted and compared within
animals between trials 1 and 2 using t-tests with
conﬁdence levels of 95%.
Results
GRP Expression in LSt Cells and Axons
GRP was co-expressed by all LSt cells, based on
analysis of 119 galanin-IR cells in eight animals
(Figure 3).Moreover, 100%GRP-IRneurons in the
lumbosacral spinal cord co-expressed galanin-IR,
suggesting that GRP is exclusively expressed by LSt
cells. There was no effect of spinal transection on
co-expression of galanin and GRP-ir. In addition,
qualitative analysis showed that virtually all
galanin-IR axons in IML, CAN, SPN, and SNB
co-expressed GRP (Figure 3). Hence, GRP may be
released in autonomic and motor areas to mediate
ejaculation. However, a few GRP-IR ﬁbers that did
not co-express galanin-IR were detected dorsal to
the SPN (Figure 3J–L), raising the possibility that
the SPN also receives a minor GRP input from cells
other than LSt neurons and outside the lumbosacral
spinal cord.
GRP Receptor Antagonist Blocked
Ejaculatory Reflexes
GRP receptor antagonist RC-3095 signiﬁcantly
reduced DPN stimulation-induced ejaculatory
reﬂexes at both 30 and 60 Hz stimulation frequen-
cies as evidenced by the reduced numbers of BCM
events and bursts (Figure 4C–F). There were main
effects of testing trial on the numbers of BCM
events for both 30 (F(1, 43) 13.760; P = 0.002;
Figure 4C) and 60 Hz stimulation frequencies
(F(1, 41) 12.727; P = 0.003; Figure 4D). Post hoc
analyses revealed that animals treated with either
dose of RC-3095 during the second, drug trial
(trial 2; Figure 4B) had signiﬁcantly decreased
BCM events in response to 30 and 60 Hz DPN
stimulation compared to their DPN stimulation-
induced BCM events following saline treatment in
their ﬁrst control trial (trial 1; 60 Hz: P = 0.008
(10 nmol); P = 0.040 (20 nmol); 30 Hz: P = 0.022
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Figure 3 Confocal images (1 mm optical sections) illustrating the co-expression of galanin-ir (A) and GRP-ir (B) in LSt cells
(A–C), IML (D–F), CAN (G–I), and SPN (J–L) in a spinal intact male rat. Galanin-ir was immunoprocessed using TSA
amplification, while GRP was immunoprocessed using a conjugated secondary antibody. Arrows in (C) indicate putative close
contacts of galanin/GRP-ir axon terminals with LSt cells. Arrows in L indicate GRP-ir fibers dorsal to the SPN that do not
co-express galanin-ir. Scale bars indicate 20 mm.
Neuropeptide Control of Ejaculation 1309
J Sex Med 2012;9:1303–1318
(10 nmol); P = 0.029 (20 nmol); Figures 4C, D and
5C, D). There were no signiﬁcant differences
between the two groups treated with the lower and
higher doses of RC-3095. Saline-treated animals
did not differ in their BCM events during trial 2
compared to trial 1 (30 Hz: P = 0.130; 60 Hz:
P = 0.280, Figures 4C, D and 5A, B), demonstrat-
ing that the reduction in BCM events was not an
effect of repeated testing, but rather of RC-3095
treatment. Similarly, there were main effects of
testing trial on the numbers of BCM bursts
for both 30 Hz (F(1,48) = 56.209; P < 0.001;
Figure 4E) and 60 Hz (F(1,48) = 41.878; P <
0.001; Figure 4F) stimulation frequencies. Males
treated with either dose of RC-3095 during trial 2
(drug trial) had signiﬁcantly lower numbers of
BCM bursts compared to trial 1 (control trial) with
saline treatment (30 Hz: P < 0.001 [10 nmol],
60 Hz: P < 0.001 [20 nmol]). Once again, there
was no effect of the dosage of the antagonist and of
repeated testing, as saline-treated animals did not
differ in the numbers of BCM bursts during the
second compared to the ﬁrst testing trial
(Figure 4E, F).
A signiﬁcant interaction between drug treat-
ment and testing trial was detected for numbers of
BCM events at the 60 Hz stimulation
(F(2,48) = 6.941; P = 0.005). Post hoc analyses
demonstrated that during trial 2 (drug trial),
animals treated with 10 nmol RC-3095 had sig-
niﬁcantly fewer numbers of BCM events induced
by 60 Hz stimulation compared to saline controls
(P = 0.004; Figure 4D). A trend towards signiﬁ-
cance was observed in animals treated with the
higher dose of RC-3095 (20 nmol) and received
60 Hz DPN stimulation (P = 0.06; Figure 4D).
Figure 4 Quantitative analysis of
BCM events and bursts following infu-
sions with GRP receptor antagonist
RC-3095 During Trial 1 (A; control
trial), all groups received saline infu-
sions (arrow) and 30 and 60 Hz DPN
stimulation (bolt arrows; in counterbal-
anced manner). During Trial 2 (B; drug
trial), the same groups received saline
or RC-3095 (10 or 20 nmol) infusions
(arrow) followed by 30 and 60 Hz DPN
stimulation (bolt arrows; in counterbal-
anced manner). Numbers of BCM
events are shown in (C) (30 Hz) and
(D) (60 Hz); while numbers of BCM
bursts are shown in (E) (30 Hz) and (F)
(60 Hz). # denotes significant differ-
ences from Trial 1 within the same
treatment group. * indicates significant
differences from controls within the
same testing trial.
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Interactions between drug treatment and testing
trial were also detected for numbers of BCM
bursts at 30 Hz (F(2,48) = 5.250; P = 0.014) and
60 Hz (F(2,48) = 6.941; P = 0.005) stimulations.
Speciﬁcally, during trial 2 (drug trial), animals
treated with the lower dose of RC-3095 had sig-
niﬁcantly lower numbers of BCM bursts compared
to saline controls for both 30 Hz (P = 0.01;
Figure 4E) and 60 Hz (P < 0.001; Figure 4F)
stimulations and animals treated with the higher
dose had fewer BCM bursts compared to saline
controls following 60 Hz stimulation (P = 0.003;
Figure 4F). There were no signiﬁcant differences
between the two groups treated with the lower and
higher doses of RC-3095. Finally, there were no
differences in numbers of BCM events nor bursts
between groups during the ﬁrst control trial, when
all groups were treated with saline (Figure 4C–F),
demonstrating that group differences during the
second testing trial were caused by drug treat-
ments, rather than differences in BCM bursting
responses.
RC-3095 Did Not Affect DPN Stimulation-Induced
pERK in LSt Cells
In order to verify that GRP antagonist RC-3095
blocks BCM bursting via actions in LSt target
areas rather than acting directly on LSt cells, DPN
stimulation-induced neural activation of LSt cells
was examined. In both antagonist-treated and
control males, DPN stimulation induced pERK in
97  0.03% of LSt cells, similar to the activation
reported previously in control males [22]. Thus,
GRP receptor antagonist treatment did not affect
the activation of LSt cells in response to DPN
stimulation (Figure 6).
GRP20–29 Agonist Facilitated BCM Activity
During the ﬁrst testing trial (control trial), there
was an overall effect of DPN stimulation param-
eters on the number of BCM events (F(4,
121) = 28.878; P < 0.001) and bursts (F(4,121) =
54.775; P < 0.001). Post hoc tests showed that fol-
lowing 30 Hz DPN stimulation, all treatment
groups had signiﬁcantly increased numbers of
BCM events (compared to infusion, 5 Hz, or
10 Hz, P < 0.001; Figure 7C), and bursts (com-
pared to infusion, 5 Hz, or 10 Hz, P < 0.001;
Figure 7E). DPN stimulation at 60 Hz also
increased numbers of BCM events and bursts
(compared to infusion, 5 Hz, or 10 Hz, P < 0.001;
Figure 7C, E). These data conﬁrm that 30 and
60 Hz stimulations reliably trigger BCM bursting
while 5 and 10 Hz represent sub-threshold levels
of stimulation. Moreover, saline infusions alone
(without DPN stimulation) did not trigger any
BCM activity (Figures 7C, E, and 8E). Finally,
during control trial 1, there were no differences
between treatment groups in the numbers of BCM
events nor bursts (Figure 7C, E), demonstrating
Figure 5 Representative EMG recording traces depicting
BCM activity induced by 60 Hz DPN stimulation (indicated
by arrow) following intrathecal infusions of saline or GRP
antagonist RC-3095. DPN stimulation induced characteris-
tic BCM bursting following infusion of saline in trial 1 (A, C)
and again following saline in trial 2 (B; same animals as A).
In contrast, infusion of the GRP antagonist RC-3095
(20 nmol) in trial 2 completely prevented BCM activity (D;
same animal as C). Each trace represents 90 seconds of
BCM activity.
Figure 6 Confocal images (1 mm
optical sections) demonstrating pERK
expression (B) in LSt cells (A) induced
by DPN-stimulation (merged image in
C). The pattern of pERK labeling is
representative of all antagonist- and
control-treated animals. Scale bar indi-
cates 20 mm.
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that there were no initial group differences in
BCM bursting responses and that repeated DPN
stimulations in the randomized order did not
affect BCM responses to subsequent stimulations.
During the second testing trial (drug trial), there
were overall effects of DPN stimulations on BCM
bursts (F(4,120) = 2.795, P = 0.031)) and there
were signiﬁcant interactions between stimulations
and drug treatments for events ((F(8, 119) = 5.048;
P < 0.001) and bursts (F(8,120) = 8.053; P < 0.001).
First, the GRP20–29 receptor agonist signiﬁcantly
triggered BCM activity in the absence of DPN
stimulation in a subset of animals (43% of 0.2 nmol
and 43% of 0.5 nmol; Figures 7D, F and 8F).
Latencies to BCM activity were 149  13.66
(0.2 nmol) and 148  5.69 (0.5 nmol) seconds post
infusion. Comparisons of numbers of BCM events
and bursts showed a signiﬁcant increase in BCM
activity in animals treated with the low dose of
GRP20–29 (0.2 nmol) compared to saline controls
(events: P = 0.015; bursts: P = 0.008) and a trend
toward signiﬁcance compared to animals treated
with the high dose of GRP20–29 (0.5 nmol; events:
P = 0.07; Figure 7D, F). These results indicate that
in a portion of the animals, the low dose ofGRP20–29
was sufﬁcient for triggering ejaculatory reﬂexes in
the absence of sensory stimulation.
Furthermore, intrathecal infusions of GRP20–29
facilitated ejaculatory reﬂexes in response to sub-
threshold levels of DPN stimulation (5–10 Hz) as
evidenced by the increased numbers of events and
bursts (Figures 7D, F, and 8D). Post hoc analyses
revealed signiﬁcantly increased BCM events in
response to DPN stimulation in animals treated
with low dose of GRP20–29 (0.2 nmol) at 5 Hz
(P = 0.022) and 10 Hz (P = 0.042) compared to
saline-treated control animals (Figure 7D). Simi-
larly, animals treatedwith the high dose ofGRP20–29
Figure 7 Quantitative analysis of
BCM events and bursts following infu-
sions with GRP20–29. During Trial 1 (A;
control trial) all groups received
intrathecal saline (arrow) followed by
four DPN stimulations (bolt arrows) at
5–60 Hz (in counterbalanced manner).
During Trial 2 (B; drug trial), all groups
received intrathecal GRP20–29 (10 or
20 nmol; arrow) again followed by four
DPN stimulations at 5–60 Hz (bolt
arrows; in counterbalanced manner).
Numbers of events are shown in (C)
(Trial 1) and (D) (Trial 2), while
numbers of bursts are shown in (E)
(Trial 1) and (F) (Trial 2). # denotes
significant differences from BCM activ-
ity following infusion, 5 Hz, and 10 Hz
within the same treatment group and
trial, * indicates significant differences
from the saline control group within the
same DPN stimulation and trial.
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(0.5 nmol) demonstrated signiﬁcantly increased
BCM events in response to 5 Hz DPN stimulation
(P = 0.012; Figure 7D). Animals treated with the
low dose of GRP20–29 (0.2 nmol) also had signiﬁ-
cantly more BCM bursts in response to 5 Hz DPN
stimulation (P = 0.016) and a trend to signiﬁcance
at 10 Hz (P = 0.041) compared to saline-treated
animals (Figure 7F). Similarly, animals treatedwith
the high dose of GRP20–29 (0.5 nmol) demonstrated
signiﬁcantly increased BCM bursts after 5 Hz
(P = 0.001) and 10 Hz (P = 0.012) DPN stimula-
tion compared to saline controls (Figure 7F).
GRP20–29 treatment did not affect BCM activity
at 30 Hz stimulation. But, unexpectedly, GRP
agonist treatment signiﬁcantly decreased BCM
activity in response to high levels of DPN stimu-
lation (60 Hz) at both the lower dose (events:
P = 0.016; bursts P < 0.001) and the higher dose
(events: P < 0.001; bursts: P < 0.001) of GRP20–29
compared to saline-treated control animals
(Figure 7D–F). Finally, saline treatment did not
affect increased BCM events and bursts following
30 Hz (Events; infusion: P = 0.007, 5 Hz: P =
0.017, 10 Hz: P = 0.037; Bursts; infusion: P <
0.001, 5 Hz: P < 0.001, 10 Hz: P = 0.001) or 60 Hz
(Events; infusion, 5 Hz, 10 Hz: P < 0.001, 30 Hz:
P = 0.006; Bursts; infusion, 5 Hz, 10 Hz: P <
0.001) DPN stimulation, conﬁrming that there
was no effect of repeated DPN stimulations
(Figure 7D–F).
GRP Mediates SVP Increases Following
DPN Stimulation
The ﬁndings described above conﬁrm a role for
GRP in the expulsion phase of ejaculatory reﬂex.
Next, we determined the role of GRP for increases
in SVP, indicative of the emission phase. Since
effects of DPN stimulation on SVP have not yet
been documented, ﬁrst saline-treated controls
were analyzed. DPN stimulation triggered SVP
increases that were concurrent with BCM EMG
bursts in saline treated animals (Figure 9). There
were no signiﬁcant differences in the numbers of
SVP increases following DPN stimulation
between trial 1 and trial 2 in animals treated with
saline (at 5, 10, 30, or 60 Hz; Table 1), showing
lack of effect of repeated DPN stimulation. Simi-
larly, and in concordance to the results described
above, there were no signiﬁcant differences in the
numbers of BCM bursts induced by DPN stimu-
lation between trial 1 and trial 2 in saline treated
animals (Table 1). The frequency of SVP increases
was closely coupled to the numbers of BCM
bursts. Each SVP increase was accompanied by a
BCM burst, although a number of DPN-
stimulation induced BCM bursts occurred in the
absence of SVP increases, in animals that received
30 or 60 Hz DPN stimulation. In the absence of
BCM activity following subthreshold levels of
DPN stimulation (Trial 1: control trial; saline
infusion, 5 Hz, and 10 Hz) there was a similar
absence of SVP increases (Table 1).
GRP appears to be critically involved in the regu-
lationofbothBCMEMGactivity andSVP increases
(Table 1, Figure 10). Indeed, RC-3095 (20 nmol)
treatment completely blocked both BCM EMG
bursts (conﬁrming results described above) and SVP
increases in response to 30 Hz (BCM: P < 0.001;
SVP: P = 0.03) and 60 Hz (BCM: P = 0.001; SVP:
P = 0.052)DPN stimulation (Table 1).Moreover, in
2/3 animals (66%), GRP20–29 triggered BCM bursts
and SVP increases in the absence of DPN stimula-
tion (Table 1, Figure 10). In addition, GRP20–29
facilitated BCM bursts and SVP increases in
response to subthreshold levels: 5 Hz (BCM: P =
Figure 8 Representative EMG recording traces showing
BCM activity induced by subthreshold stimulation of the
DPN (5 Hz; indicated by bolt arrows) following intrathecal
infusion of saline (A–C) or GRP20–29 (D). Subthreshold DPN
stimulation did not induce BCM activity following intrathecal
infusions of saline in trial 1 (A, C), or following saline in trial
2 (B; same animal as A). In contrast, subthreshold DPN
stimulation following intrathecal infusion of GRP20–29
(0.2 nmol) did induce BCM activity (D; same animal as C).
Infusion of GRP20–29 (0.2 nmol) (F) but not saline (E; same
animal as F) also induced BCM activity without DPN stimu-
lation. Each trace represents 90 seconds of BCM activity.
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0.004; SVP: P = 0.005) and 10 Hz (BCM: P = 0.005;
SVP: P = 0.013) of DPN stimulation (Table 1).
Discussion
The ﬁndings of this set of studies support the
hypothesis that GRP plays a critical role in the
control of ejaculation by acting in autonomic and
motor areas targeted by LSt axons. GRP was
found to be present in all LSt cells and LSt axon
projections within the lumbosacral spinal cord. As
predicted, intrathecal administration of GRP
receptor antagonist RC-3095 severely disrupted
both the emission and expulsion phases of ejacu-
lation in response to sensory stimulation, reﬂected
in the reduced numbers of SVP increases and
BCM activity in response to DPN stimulation in
RC-3095-treated male rats. In contrast, intrathe-
cal infusion of GRP20–29 facilitated both the emis-
sion and expulsion phases of ejaculation, as
evidenced by the surge in the numbers of SVP
increases and BCM bursts respectively in male rats
treated with GRP20–29. In particular, GRP20–29 was
most effective in facilitating ejaculation after sub-
Figure 9 A representative example of a simultaneous recording of BCM activity and SVP (90 seconds duration) after 60 Hz
DPN stimulation 10 minutes following intrathecal saline infusion. The dotted lines in A and B indicate the end of DPN
stimulation. Stars in (B) indicate SVP increases. A fragment of the trace indicated in the box area in A and B is enlarged in
C and D to clearly show a BCM burst (C) coupled with a single increase in SVP (D) over 4 seconds of recording.
Table 1 Numbers of seminal vesicle pressure (SVP) increases and BCM bursts in animals treated with saline-saline
(N = 3), saline-RC3095 (20 nmol; N = 3) or saline-GRP (0.2 nmol; N = 3) in trial 1-trial 2, respectively, and with DPN
stimulation at 0, 5, 30, or 60 Hz frequencies
Saline-saline
(N = 3)
Trial 1: Numbers
of SVP
Trial 2: Numbers
of SVP
Trial 1: Numbers
of BCM bursts
Trial 2: Numbers
of BCM bursts
Infusion 0 0 0 0
5 Hz 0 0 0 0
10 Hz 0 0 0 0
30 Hz 3.33  1.43 2.33  0.94 8  1.08 8.33  0.62
60 Hz 4  0.71 2.33  1.03 8.33  0.24 9.33  0.62
Saline-RC3095
20 nmol (N = 3)
Trial 1: Numbers
of SVP
Trial 2: Numbers
of SVP
Trial 1: Numbers
of BCM bursts
Trial 2: Numbers
of BCM bursts
30 Hz 4.66  1.86 0* 6.66  0.47 0*
60 Hz 3.66  2.03 0 (P = 0.052) 8  0.71 0*
Saline-GRP
0.2 nmol (N = 3)
Trial 1: Numbers
of SVP
Trial 2: Numbers
of SVP
Trial 1: Numbers
of BCM bursts
Trial 2: Numbers
of BCM bursts
Infusion 0 3.66  1.89 0 5  2.86
5 Hz 0 1.33  0.24* 0 4.33  0.62*
10 Hz 0 2  0.41* 0 4  0.71*
30 Hz 1  0.41 3.33  0.47* 7.33  0.62 6.66  0.62
60 Hz 4.33  2.09 2  0.41 8  0.41 6.33  0.62
*Indicates significant difference from trial 1 within the same treatment group and stimulation parameter
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threshold sensory stimulation (5–10 Hz), signify-
ing the presence of a cumulative effect of GRP
receptor activation by intrathecal infusion of GRP
and the release of endogenous GRP or other neu-
ropeptides in response to stimulation of the DPN.
GRP is a bombesin-like peptide that is widely
distributed in the central nervous system of
mammals [33] and is involved in many physiologi-
cal processes including the suppression of feeding
behavior [34], circadian rhythms [35–37] and
itching behavior [38]. In the lumbosacral spinal
cord, GRP was shown here to be exclusively
expressed by LSt cells, as 100% of LSt neurons,
identiﬁed by immunoreactivity for galanin,
co-expressed GRP and vice versa. Moreover, vir-
tually all galanin-IR LSt axons in the autonomic
and motor areas co-expressed GRP. This ﬁnding is
in slight contrast with a previous report of a sub
population of GRP-IR neurons that do not
co-express galanin dorsal to the central canal in the
lumbar spinal cord [18]. The discrepancy is pos-
sible due to differences in the sensitivity of immu-
nohistochemical detections: in the present study,
two different immunohistochemistry protocols
were performed in which either one of the neu-
ropeptide signals were ampliﬁed for optimal
sensitivity of peptide detection. Results from both
protocols were identical and complete co-
localization of galanin- and GRP-ir was found in
soma and axon terminals. Moreover, the present
study utilized spinal cord tissues from both spinal
intact and spinal transected male rats, thereby cor-
recting for the possibility of supraspinal inﬂuences
on galanin or GRP expression. A few GRP-IR
ﬁbers that did not co-express galanin-IR were
observed in the region of and dorsal to the SPN,
suggesting that the SPN receives inputs from GRP
neurons outside of the spinal ejaculation generator
and the lumbosacral spinal cord. Sources of GRP
indeed exist outside of the spinal ejaculatory
network [33]. The SPN is known for its role in
erectile function [39–41] and emission [26,42] and
destruction of sacral autonomic centers abolishes
reﬂex erections [43] but a speciﬁc role for SPN in
the expulsion phase of ejaculation has not been
documented. Therefore, it is likely that GRP
axons located dorsally to the SPN are predomi-
nantly involved in erectile function and emission,
but not expulsion [31,41,44]. Indeed, one of the
sources of GRP outside of the spinal ejaculation is
the paraventricular nucleus of the hypothalamus
[33], an area well known to be involved in erectile
function [45,46] and to project to the lumbosacral
spinal cord [41,47]. It is currently unknown if GRP
in the PVN or its projections mediate erection,
and this possibility can be tested in future studies.
The expression of GRP in LST cells and projec-
tions is consistent with the proposed role ofGRP in
control of ejaculation via action in autonomic and
motor areas in the lumbosacral spinal cord (see
Figure 3), Moreover, intrathecal injections of GRP
receptor antagonist RC-3095 blocked BCM burst-
ing in response to DPN stimulation. It is assumed
that RC-3095 acted primarily in the areas of the
spinal cord that are located adjacent to the pia-
arachnoid space, including all LSt target areas.
Indeed, GRP receptor expression has been
reported in the SPN and SNB of the lumbosacral
spinal cord [18], however its expression in otherLSt
target regions, including the CAN and IML
requires further investigation. Another possibility
is that GRP or GRP antagonist treatment acts
directly on theLSt cells.Galanin- andGRP-ir axon
terminals arising from LSt cells that make putative
Figure 10 Simultaneous recording of BCM activity (A) and SVP (B) in one animal (45 seconds of EMG recording) 145
seconds after an intrathecal infusion of GRP20–29 (0.2 nmol). The traces in A and B are magnified to show one BCM burst (C)
occurring simultaneously with an increase in SVP (D).
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contacts with LSt cells have previously been
observed (see Figure 5; [17]) and thus GRP may be
released directly onto LSt cells to control ejacula-
tion. However, RC-3095 treatment did not
decrease neural activity of LSt cells, indicated by
pERK expression, substantiating that RC-3095
likely blocks the ejaculatory reﬂex by acting on
GRP receptors downstream of the LSt cells, rather
than directly disrupting activity of LSt cells.
In a portion of the animals (43–66%), GRP20–29
was sufﬁcient in triggering ejaculatory reﬂexes in
the absence of DPN stimulation. It is possible that
the differences in the ability of GRP to induce
ejaculatory reﬂexes between groups of rats are due
to differences in receptor densities for neuropep-
tides or receptors expressed in the spinal ejaculation
generator, including GRP. In addition, GRP20–29
was not sufﬁcient to trigger ejaculatory reﬂexes in
all the animals indicating that a higher dose ofGRP
agonist may have been necessary to trigger BCM
bursting and SVP increases in some animals. Alter-
natively, the lack of responses to GRP20–29 in all
animals suggests that other neuropeptides
expressed in LSt cells and potentially released in
LSt target areas may act in concert with GRP to
control ejaculation. These neuropeptides include
galanin [25], cholecystokinin [14], and enkephalin
[20]. An unexpected ﬁnding was that the higher
dosages of GRP20–29 caused signiﬁcant suppression
of BCM activity induced by the highest stimulation
parameters. A similar ﬁnding is that stimulation of
the DPN at higher frequencies (such as 120 Hz)
does not trigger ejaculatory reﬂexes (unpublished
personal observations). Hence, such stimulation by
agonists and high frequency may represent a super
physiological manipulation that leads to dysfunc-
tion or possible muscle fatigue.
An advantage of the current study of the role of
GRP in ejaculation is the use of the DPN stimu-
lation paradigm which utilizes anesthetized and
spinalized male rats and elicits rhythmic contrac-
tions of the BCM and concurrent SVP increases,
akin to those observed in freely-moving animals
during mating [4,5,8,22,23,48]. Thus, complete
transection of the spinal cord permits the study of
ejaculation as a reﬂex response in the absence of
supraspinal inﬂuences [49–51]. The DPN is the
primary afferent that transmits sensory informa-
tion related to the summation of mating to the
spinal ejaculation generator and triggers ejacula-
tion [52,53]. Indeed, bilateral transection of the
DPN blocks ejaculation in mating rats [54].
Although the pathways whereby sensory informa-
tion is transmitted from the DPN to the LSt cells
are currently unknown, it has been shown that
DPN nerve ﬁbers terminate in the lower lumbar
and upper sacral levels of the spinal cord in the
general vicinity of the LSt cells, dorsal horn and
dorsal grey commissure (DCG) [31,52,55]. Fur-
thermore, it has previously been shown that DPN
stimulation activates LSt cells in a similar manner
as ejaculatory behavior in freely moving animals
[22,23]. The mechanism for LSt cell activation is
through NMDA receptors [23] and map kinase
signaling [22]. Moreover, this activation is
required as pharmacological blockade of either of
these components results in the blockade of DPN
stimulation-induced ejaculatory reﬂexes in male
rats [22,23]. Therefore, the activation of LSt cells
is essential for the transmission of sensory infor-
mation from the DPN to the outputs of the spinal
cord ejaculation generator [56]. A previous study
demonstrated effects of GRP treatment on erectile
and ejaculatory reﬂexes using an ex copula para-
digm in spinal intact rats [18]. However, in this
paradigm, it is not possible to eliminate actions of
GRP on the supraspinal areas that control ejacu-
lation from the spinal ejaculation generator,
including the nucleus of the paragigantocellularis
(nPGi) [57–59], the medial preoptic area (MPOA)
[60] and the paraventricular nucleus of the hypo-
thalamus [58,61–63]. Moreover, emissions or
ejaculations as observed in the ex-copula paradigm
are not dependent on the spinal ejaculation gen-
erator [56] as lesions of the LSt cells did not block
sexual reﬂexes using this paradigm. While, in con-
trast, intact LSt cells were pivotal for ejaculatory
reﬂexes as induced in three accepted paradigms for
ejaculation [56], including DPN or urethrogenital
stimulation, and pharmacological activation of D3
receptors in spinal transected anesthetized male
rats [56] as well as for ejaculatory behavior in freely
mating male rats [13].
In conclusion, these data conﬁrm that GRP
receptor activation in the lumbosacral spinal cord
is required for sensory stimulation-induced ejacu-
lation reﬂex in anesthetized, spinalized male rats.
Furthermore, GRP appears to act by activating
receptors in the outputs of the LSt cells. However,
GRP receptor expression in the target regions of
the LSt cells remains to be elucidated. In addition,
the roles of other neuropeptides expressed in the
LSt axons, including enkephalin, galanin and
cholecystokinin in the control of ejaculatory
behavior and reﬂexes remain to be investigated.
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